Form 8-K - Current report:
SEC Accession No. 0001628280-17-007773
Filing Date
2017-08-01
Accepted
2017-08-01 16:59:22
Documents
3
Period of Report
2017-08-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - TOTECT US SHIPMENTS a8k-totectusshipments.htm 8-K 30298
2 EXHIBIT 99.1 PRESS RELEASE - TOTECT DISTRIBUTION pressrelease-totectdistrib.htm EX-99.1 16121
3 cumberlanda06.gif GRAPHIC 10657
  Complete submission text file 0001628280-17-007773.txt   62223
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17997380
SIC: 2834 Pharmaceutical Preparations